As blockbuster drugs fizzle, biotech looks warily to the next big thing
October 24, 2017Comments Off on As blockbuster drugs fizzle, biotech looks warily to the next big thing Posted in: Insights
Damian Garde, Posted with permission from STAT Has the age of the biotech blockbuster come to a close? Over the past year, a string of would-be best-sellers, expected to generate…
The post As blockbuster drugs fizzle, biotech looks warily to the next big thing appeared first on DrugPatentWatch - Make Better Decisions.